Browse Pet Safety Reports
17,908 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 17,908 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 17,908 FDA veterinary adverse event reports for Horse.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Jun 6, 2025 | Horse | Friesian | MSK | Lack of efficacy - NOS | Ongoing |
| Jun 6, 2025 | Horse | Unknown | MSK | Joint swelling | Outcome Unknown |
| Jun 6, 2025 | Horse | Thoroughbred | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Jun 6, 2025 | Horse | Thoroughbred | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Jun 6, 2025 | Horse | Warmblood (unspecified) | MSK | Lack of efficacy - NOS | Ongoing |
| Jun 5, 2025 | Horse | Thoroughbred | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Jun 5, 2025 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Jun 5, 2025 | Horse | Warmblood - Dutch, Warmbloo... | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Jun 5, 2025 | Horse | Morgan | MSK | Lack of efficacy - NOS | Ongoing |
| Jun 5, 2025 | Horse | Hanovarian | MSK | Gastric ulcer; Hives (see also Skin); Skin disorders NOS; Weight loss; Off fo... | Ongoing |
| Jun 5, 2025 | Horse | Quarter Horse | MSK | Collapse (see also Cardio-vascular and Systemic disorders); Pale mucous membr... | Died |
| Jun 5, 2025 | Horse | Quarter Horse | MSK | Collapse (see also Cardio-vascular and Systemic disorders); Pale mucous membr... | Died |
| Jun 5, 2025 | Horse | Crossbred Equine/horse, Qua... | MSK | Lack of efficacy (protozoa) - NOS; Death by euthanasia | Euthanized |
| Jun 5, 2025 | Horse | Horse (unknown) | MSK | Death | Died |
| Jun 5, 2025 | Horse | Quarter Horse | MSK | Collapse (see also Cardio-vascular and Systemic disorders); Pale mucous membr... | Died |
| Jun 5, 2025 | Horse | Quarter Horse | MSK | Anaphylaxis; Ataxia; Collapse (see also Cardio-vascular and Systemic disorder... | Died |
| Jun 5, 2025 | Horse | Quarter Horse | MSK | Collapse (see also Cardio-vascular and Systemic disorders); Pale mucous membr... | Died |
| Jun 5, 2025 | Horse | Quarter Horse | MSK | Anaphylaxis; Ataxia; Collapse (see also Cardio-vascular and Systemic disorder... | Died |
| Jun 4, 2025 | Horse | Unknown | MSK | Anaphylactoid reaction | Recovered/Normal |
| Jun 3, 2025 | Horse | Hanovarian | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Jun 3, 2025 | Horse | Horse (unknown) | MSK | Injection site pain | Outcome Unknown |
| Jun 2, 2025 | Horse | Quarter Horse | MSK | Rolling; Behavioural disorder NOS; Colic; Aggression; Biting -aggression (see... | Recovered/Normal |
| Jun 2, 2025 | Horse | Warmblood (unspecified) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Jun 2, 2025 | Horse | Horse (unknown) | MSK | Depression; Not eating; Behavioural disorder NOS | Recovered/Normal |
| Jun 1, 2025 | Horse | Missouri Fox Trotting Horse | MSK | Laminitis | Outcome Unknown |
| Jun 1, 2025 | Horse | Horse (unknown) | MSK | Sedation prolonged; Hives (see also Skin) | Recovered/Normal |
| May 29, 2025 | Horse | Unknown | MSK | Colic | Outcome Unknown |
| May 28, 2025 | Horse | Tennessee Walking Horse | MSK | Colic; Rolling; Sternoabdominal recumbency; Death by euthanasia | Euthanized |
| May 28, 2025 | Horse | Tennessee Walking Horse | MSK | Colic; Rolling; Sternoabdominal recumbency; Death by euthanasia | Euthanized |
| May 28, 2025 | Horse | Warmblood (unspecified) | MSK | Lack of efficacy - NOS | Ongoing |
| May 28, 2025 | Horse | Tennessee Walking Horse | MSK | Colic; Rolling; Sternoabdominal recumbency; Death by euthanasia; Lateral recu... | Euthanized |
| May 27, 2025 | Horse | Horse (unknown) | MSK | Lying down; Not eating; Colic; Abdominal pain | Recovered/Normal |
| May 27, 2025 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Ongoing |
| May 26, 2025 | Horse | Quarter Horse | MSK | Drug administration duration too long; Potency, Low; INEFFECTIVE, ANTIINFLAMM... | Recovered/Normal |
| May 26, 2025 | Horse | Quarter Horse | MSK | Drug administration duration too long; Potency, Low; INEFFECTIVE, ANTIINFLAMM... | Recovered/Normal |
| May 25, 2025 | Horse | Unknown | MSK | Lethargy (see also Central nervous system depression in Neurological) | Outcome Unknown |
| May 24, 2025 | Horse | Thoroughbred | MSK | Lack of efficacy - NOS | Outcome Unknown |
| May 23, 2025 | Horse | Thoroughbred | MSK | Injection site abscess; Injection site swelling; Injection site pain | Outcome Unknown |
| May 23, 2025 | Horse | Oldenburg | MSK | Not eating; Ataxia; Sedation; Lying down; Intestinal disorder NOS; Colic | Recovered/Normal |
| May 23, 2025 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| May 23, 2025 | Horse | Warmblood - Dutch | MSK | Injection site swelling | Outcome Unknown |
| May 22, 2025 | Horse | Thoroughbred | MSK | Lack of efficacy - NOS | Outcome Unknown |
| May 21, 2025 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS; Seizure NOS | Outcome Unknown |
| May 21, 2025 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Ongoing |
| May 21, 2025 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Outcome Unknown |
| May 20, 2025 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Outcome Unknown |
| May 20, 2025 | Horse | Thoroughbred | MSK | Lack of efficacy - NOS | Outcome Unknown |
| May 16, 2025 | Horse | Miniature | MSK | Recumbency; Increased respiratory rate; Increased heart rate; Hypersensitivit... | Recovered/Normal |
| May 16, 2025 | Horse | Paint | MSK | Bloated; Intestinal impaction; Death by euthanasia | Euthanized |
| May 16, 2025 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.